Table 2 Microbiological distribution, infection source and source control of bacteremic patients with liver cirrhosis (n = 104).

From: Afebrile Bacteremia in Adult Emergency Department Patients with Liver Cirrhosis: Clinical Characteristics and Outcomes

 

Afebrile group (n = 55)

Febrile group (n = 49)

p value

Gram-positive pathogen, n (%)

19 (34.5)

14 (28.6)

0.51

Staphylococcus aureus

5 (9.1)

2 (4.1)

 

Group B Streptococcus

3 (5.5)

1 (2.0)

 

Viridans streptococcus

1 (1.8)

3 (6.1)

 

Others

10 (18.2)

8 (16.3)

 

Gram-negative pathogen, n (%)

31 (56.4)

31 (63.3)

0.47

Escherichia coli

12 (21.8)

12 (24.5)

 

Klebsiella pneumoniae

9 (16.4)

8 (16.3)

 

Aeromonas sobria

3 (5.5)

1 (2.0)

 

Aeromonas hydrophila

1 (1.8)

3 (6.1)

 

Others

6 (10.9)

7 (14.3)

 

Polymicrobial, n (%)

5 (9.1)

4 (8.2)

1.00

Infection source, n (%)

Respiratory tract infection

4 (7.3)

3 (6.1)

1.00

Urinary tract infection

6 (10.9)

7 (14.3)

0.60

Spontaneous bacterial peritonitis

20 (36.4)

17 (34.7)

0.86

Biliary tract infection

3 (5.5)

6 (12.2)

0.30

Soft tissue infection

9 (16.4)

5 (10.2)

0.36

Primary bacteremiaa

13 (23.6)

11 (22.4)

0.89

Source controlb, n (%)

5 (9.1)

4 (8.2)

1.00

  1. a - source of unknown origin.
  2. b - measures used to eliminate the source of infection.